Track: Skin Diseases: Acne, Psoriasis, Dermatitis

Skin Diseases: Acne, Psoriasis, Dermatitis

The "Skin Diseases: Acne, Psoriasis, Dermatitis" is designed to explore the complexities and challenges of some of the most common yet impactful dermatological conditions. These skin diseases affect millions of people worldwide, influencing not only their physical health but also their mental and emotional well-being. This session will cover the most recent findings, approaches to therapy, and new developments in the field of treating these disorders. It will provide a thorough grasp of the causes, consequences, and cutting-edge therapeutic approaches of these conditions.

Acne:
Acne is a widespread condition that affects both adolescents and adults, characterized by pimples, blackheads, and cysts. This sub-session will explore the latest treatments, preventive strategies, and the psychological impact of acne on patients.

Psoriaisis:
Psoriasis is a chronic autoimmune disease that causes rapid skin cell turnover, leading to thick, scaly patches. This session will cover the pathophysiology, innovative therapies, and the role of lifestyle modifications in managing psoriasis.

Dermatitis:
Dermatitis encompasses various inflammatory skin conditions, including atopic dermatitis and contact dermatitis. This will discuss the triggers, treatment options, and ongoing research aimed at improving patient outcomes.

Rosacea:
Rosacea is a chronic skin condition that primarily affects the face, causing redness, swelling, and sometimes acne-like breakouts. This sub-track will highlight the latest diagnostic tools, treatment modalities, and ongoing research to better understand this condition.

Blistering diseases:
Blistering diseases, such as pemphigus and bullous pemphigoid, involve painful blisters and sores on the skin and mucous membranes. This will focus on the underlying mechanisms, diagnostic challenges, and advancements in treatment strategies for these conditions.

Hyperpigmentation disorders:
Hyperpigmentation disorders, such as melasma and post-inflammatory hyperpigmentation, result in darkened areas of skin due to excess melanin production. This sub-session will examine the causes, current treatment options, and emerging therapies aimed at addressing these conditions effectively.